FDA Compliant - Search News

FDA approves 1st weight-loss pill

Digest more

· 9h

FDA approves Wegovy pill for weight loss: What to know

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance.

· 13h

The FDA just approved the first GLP-1 weight-loss pill. Here’s what to know

· 3h · on MSN

FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind

· 4h

FDA approves pill version of Wegovy

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity

· 1d

US regulators approve Wegovy pill for weight loss

· 14h

FDA approves first pill version of GLP-1 drugs

FDA OKs libido-boosting pill for older, postmenopausal women

The once-a-day treatment, which acts on brain chemicals that affect mood and appetite, had initially been OK’d for premenopausal women

MedPage Today on MSN

New drug approved for hypertrophic cardiomyopathy

The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced.

The FDA Just Approved Addyi, 'The Little Pink Pill,' To Treat Low Sexual Desire In Postmenopausal Women

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for postmenopausal women, which makes this the first medication for low sexual desire for pre- and postmenopausal women under the age of 65.

FDA approves first subcutaneous drug for EGFR-mutated non-small cell lung cancer

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).